146 related articles for article (PubMed ID: 32047552)
41. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
42. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
Yao J; Pollock RE; Lang A; Tan M; Pisters PW; Goodrich D; El-Naggar A; Yu D
Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903
[TBL] [Abstract][Full Text] [Related]
43. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
Milde-Langosch K; Riethdorf S; Kraus-Pöppinghaus A; Riethdorf L; Löning T
Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
[TBL] [Abstract][Full Text] [Related]
44. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.
Lukas J; Parry D; Aagaard L; Mann DJ; Bartkova J; Strauss M; Peters G; Bartek J
Nature; 1995 Jun; 375(6531):503-6. PubMed ID: 7777060
[TBL] [Abstract][Full Text] [Related]
45. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
[TBL] [Abstract][Full Text] [Related]
46. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
Shapiro GI; Edwards CD; Rollins BJ
Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
[TBL] [Abstract][Full Text] [Related]
47. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.
Jiang M; Milner J
Oncogene; 2002 Sep; 21(39):6041-8. PubMed ID: 12203116
[TBL] [Abstract][Full Text] [Related]
48. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
49. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers.
Reuschenbach M; Waterboer T; Wallin KL; Einenkel J; Dillner J; Hamsikova E; Eschenbach D; Zimmer H; Heilig B; Kopitz J; Pawlita M; Doeberitz Mv; Wentzensen N
Int J Cancer; 2008 Dec; 123(11):2626-31. PubMed ID: 18785210
[TBL] [Abstract][Full Text] [Related]
50. Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells.
Wang J; Sampath A; Raychaudhuri P; Bagchi S
Oncogene; 2001 Aug; 20(34):4740-9. PubMed ID: 11498796
[TBL] [Abstract][Full Text] [Related]
51. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.
Li Y; Nichols MA; Shay JW; Xiong Y
Cancer Res; 1994 Dec; 54(23):6078-82. PubMed ID: 7954450
[TBL] [Abstract][Full Text] [Related]
52. Cyclin-dependent kinase (cdk6) and p16 in pancreatic endocrine neoplasms.
Tomita T
Pathology; 2004 Dec; 36(6):566-70. PubMed ID: 15841692
[TBL] [Abstract][Full Text] [Related]
53. Most basal-like breast carcinomas demonstrate the same Rb-/p16+ immunophenotype as the HPV-related poorly differentiated squamous cell carcinomas which they resemble morphologically.
Subhawong AP; Subhawong T; Nassar H; Kouprina N; Begum S; Vang R; Westra WH; Argani P
Am J Surg Pathol; 2009 Feb; 33(2):163-75. PubMed ID: 18936692
[TBL] [Abstract][Full Text] [Related]
54. Structural analysis of the inhibition of Cdk4 and Cdk6 by p16(INK4a) through molecular dynamics simulations.
Villacañas O; Pérez JJ; Rubio-Martínez J
J Biomol Struct Dyn; 2002 Dec; 20(3):347-58. PubMed ID: 12437373
[TBL] [Abstract][Full Text] [Related]
55. Down-regulation of p16 and MGMT promotes the anti-proliferative and pro-apoptotic effects of 5-Aza-dC and radiation on cervical cancer cells.
Chen GD; Qian DY; Li ZG; Fan GY; You KL; Wu YL
Cell Biochem Funct; 2017 Dec; 35(8):488-496. PubMed ID: 29143344
[TBL] [Abstract][Full Text] [Related]
56. Correlation of p16(INK4A) expression and HPV copy number with cellular FTIR spectroscopic signatures of cervical cancer cells.
Ostrowska KM; Garcia A; Meade AD; Malkin A; Okewumi I; O'Leary JJ; Martin C; Byrne HJ; Lyng FM
Analyst; 2011 Apr; 136(7):1365-73. PubMed ID: 21290054
[TBL] [Abstract][Full Text] [Related]
57. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
[TBL] [Abstract][Full Text] [Related]
58. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations].
Liu JH; Huang H; Huang X; Zeng MS; Li W
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):312-6. PubMed ID: 16677523
[TBL] [Abstract][Full Text] [Related]
59. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
60. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
